FindMyRecallSubscribe
Class I: serious health riskTerminated

Cipla Albuterol Sulfate Inhalation Aerosol Recall

Albuterol Sulfate Inhalation Aerosol, 90 mcg, 200 Metered Inhalation

Cipla USA, Inc. · Warren, NJ

Risk level
Class I
Reported by FDA
Jul 19, 2023
Recall ID
D-0938-2023
Check your lot numberHow we source this data

Summary

Cipla recalled Albuterol Sulfate Inhalation Aerosol starting Jun 27, 2023. The FDA classified it as Class I (serious health risk) and published enforcement report D-0938-2023 on Jul 19, 2023. Reason: Defective container: empty inhaler and leakage observed through the inhaler valve due to partially missing bottom seat (gasket). Status: Terminated.

Why it was recalled

Defective container: empty inhaler and leakage observed through the inhaler valve due to partially missing bottom seat (gasket).

Product description

Albuterol Sulfate Inhalation Aerosol, 90 mcg, 200 Metered Inhalation, net content 6.7 g canister packaged in a box, Rx only, Manufactured by: Cipla Ltd, Indore SE Z, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ, 07059, NDC 69097-142-60

Lot numbers, UPCs & expiration codes

Lot # IB20045, IB20055, IB20056, IB20057, IB20059, IB20072, Exp Nov. 30, 2023

Where it was sold

Nationwide in the US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0938-2023
Classification
Class I
Status
Terminated
Recall initiated
Jun 27, 2023
FDA report date
Jul 19, 2023
Quantity
278,538 canisters
Recall type
Voluntary: Firm initiated
Recalling firm
Cipla USA, Inc.

Original FDA data

Every field from FDA enforcement report D-0938-2023, exactly as published.

Show all FDA fields
City
Warren
State
NJ
Status
Terminated
Country
United States
Event ID
92616
Address
10 Independence Blvd
Code information
Lot # IB20045, IB20055, IB20056, IB20057, IB20059, IB20072, Exp Nov. 30, 2023
Postal code
07059-2730
Report date
Jul 19, 2023
Product type
Drugs
Recall number
D-0938-2023
Classification
Class I
Recalling firm
Cipla USA, Inc.
Product quantity
278,538 canisters
Termination date
Mar 6, 2025
Reason for recall
Defective container: empty inhaler and leakage observed through the inhaler valve due to partially missing bottom seat (gasket).
Voluntary / mandated
Voluntary: Firm initiated
Product description
Albuterol Sulfate Inhalation Aerosol, 90 mcg, 200 Metered Inhalation, net content 6.7 g canister packaged in a box, Rx only, Manufactured by: Cipla Ltd, Indore SE Z, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ, 07059, NDC 69097-142-60
Distribution pattern
Nationwide in the US
Recall initiation date
Jun 27, 2023
Initial firm notification
Letter
Center classification date
Jul 21, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0938-2023, published Jul 19, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls